• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
The Impact Investor | ESG Investing Blog

The Impact Investor | ESG Investing Blog

Investing for financial return is only part of the equation.

  • ESG Investment Products
    • Best Impact Investing Apps
    • Best ESG Funds
    • Best Socially Responsible Mutual Funds
    • Best BlackRock SRI Funds
    • Best Vanguard ESG Funds
    • Best Sustainable Robo-Advisors
  • ESG Education
    • How to Build a Socially Responsible IRA Portfolio
    • ESG Principles
    • ESG Shareholder Activism
    • Why You Need ESG Investing
    • ESG Investing Trends
    • Social Impact Examples
    • Impact Investing Examples
  • Careers in ESG
    • Best ESG Jobs
    • Best Corporate Responsibility Jobs
    • Environmental Justice Jobs
JOIN

Johnson & Johnson ESG Profile (JNJ): Is It Sustainable?

Updated on July 12, 2024

Our posts may contain links from our affiliate partners. This supports helps support the site as we donate 10% of all profits to sustainability organizations that align with our values. However, this does not influence our opinions or ratings. Please read our Terms and Conditions for more information.

Home • Stocks • Pharmaceuticals

Our Johnson & Johnson (JNJ) ESG Review

Johnson & Johnson
$151.33
SymbolJNJ
Price$151.33
52 Week High 📈$169.99
52 Week Low 📉$140.68
Earnings Per Share 💵8.99
Dividend Yield 🔁3.44

Our Take

Johnson & Johnson is a global healthcare company that manufactures and sells a wide range of consumer products, pharmaceuticals, and medical devices. The company has been in operation for over 130 years and has a strong reputation for quality and innovation. Johnson & Johnson is also a leader in environmental, social, and governance (ESG) initiatives. The company was one of the first to adopt sustainable manufacturing practices and has since been an industry leader in reducing its environmental impact.

Johnson & Johnson is also a signatory of the United Nations Global Compact, the world’s largest corporate sustainability initiative. In addition, the company has been named one of the World’s Most Ethical Companies by the Ethisphere Institute for 12 consecutive years. Johnson & Johnson is committed to being a good steward of the environment and to improving the lives of its employees, customers, and communities.

What We Like
  • Diversified portfolio of businesses across healthcare, consumer, and pharmaceuticals

  • Strong track record of consistent and sustainable growth

  • Leading position in several key markets

What We Don't Like
  • Relying on blockbuster drugs for a large portion of sales

  • Potential negative impact from US healthcare reform

Sector: Health Care
Industry: Pharmaceuticals
Website: www.jnj.com
Business Description

Johnson & Johnson researches and develops, manufactures, and sells a range of products in the health care field worldwide. It operates through three segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment offers baby care products under the JOHNSON’S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; smoking cessation products under the NICORETTE brand; and acid reflux products under the PEPCID brand. This segment also provides women’s health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides electrophysiology products to treat cardiovascular diseases and neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.

CompanyJohnson & Johnson
ExchangeNYSE
AddressOne Johnson & Johnson Plaza,, New Brunswick, USA
Go to top

Popular ESG Stocks

Popular ESG Stocks
StockMarketcapIndustryPriceChange %52 Week RangeChart (24H)EPSDividend Yield
NVDA
NVIDIA Corporation
NVDA
3.30TSemiconductors$135.400.42%
2.940.03%
MSFT
Microsoft Corporation
MSFT
3.38TSoftware - Infrastructure$454.270.25%
12.950.73%
BBY
Best Buy Co., Inc.
BBY
15.62BSpecialty Retail$73.801.32%
4.285.15%
ADBE
Adobe Inc.
ADBE
177.78BSoftware - Application$417.133.07%
15.140.00%
CRM
Salesforce, Inc.
CRM
279.35BSoftware - Application$291.150.13%
6.350.57%
INTU
Intuit Inc.
INTU
187.38BSoftware - Application$670.281.36%
10.660.62%
POOL
Pool Corporation
POOL
12.06BIndustrial Distribution$320.822.33%
10.681.56%
PYPL
PayPal Holdings, Inc.
PYPL
70.20BCredit Services$72.180.85%
4.450.00%
GOOGL
Alphabet Inc.
GOOGL
2.02TInternet Content & Information$166.191.36%
8.960.51%
FSLR
First Solar, Inc.
FSLR
19.14BSolar$178.464.15%
11.780.00%

FAQ

How much is Johnson & Johnson (JNJ) stock?

The current stock price of Johnson & Johnson (JNJ) is $151.33.

What is Johnson & Johnson (JNJ)'s ESG Score?

Johnson & Johnson (JNJ) has an ESG score of 65, BBB, and bbb as rated from Sustainalytics, ESG Enterprise, and MSCI, respectively.

Stocks

Johnson & Johnson
$151.33
Open $149.67
High $151.49
Close $149.61
Low $149.22
Volume 6,268,118

Popular ESG Stocks
Nvidia Logo NVDA
Microsoft Logo MSFT
Adobe Logo ADBE
Salesforce Logo CRM

Buy Johnson & Johnson for $151.33

Polar BearPolar Bear on Ice on Ice

Future Generations Will Thank You

Join the newsletter and learn how you can make a invest for financial return and make a positive impact.

JOIN NOW

Footer

About

The Impact Investor is a blog focused on helping retail investors find ESG, socially responsible, and impact investment opportunities through our expert insights, tips, and blog posts.

Resources

  • Best ESG Jobs
  • Best ESG Stocks
  • Best EV Battery Stocks
  • Best ESG Analysis Tools
  • How to Finance Solar Panels

Tools

  • Tesla Charging Calculator
  • Solar Loan Calculator
  • PACE Loan Calculator
  • Electric Bill Calculator

Products

  • Best Investing Apps
  • Best Robo-Advisors
  • Best ESG Funds
  • Vanguard ESG Funds
  • Best Green Credit Cards

Marketplace

  • Community Solar Providers
  • Best Car Insurance for EVs
  • Best Home Solar Systems
  • Best Green Auto Loans

Contact

  • About
  • Contact Us
  • Privacy Policy
  • Disclaimer
  • Facebook
  • Instagram
  • Twitter
  • YouTube

Copyright © 2025 The Impact Investor